Managing Osteoarthritis-associated Pain
Clinical guidelines
- Non-steroidal anti-inflammatory drug (NSAID) treatment remains strongly recommended
- Use of paracetamol and opioids has been downgraded because of lack of efficacy and risk of adverse reactions
- Personalised treatment for each patient is recommended, including consideration of comorbidities and risk factors
- Multidisciplinary approaches are increasingly recommended, but strong evidence of their superior benefits remains elusive
Find out about the emerging therapies that could be available to Marie in the future in the next section of the Learning Zone.
This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.